Vertex Pharmaceuticals Stock Is Down 13%. Here's Why You Should Buy the Dip
Despite the real problems with the additional indication being sought for suzetrigine, this drop in the stock is still an ...
Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in ...
Different genetic mutations cause different problems with this particular protein -- so CFTR modulators generally don't work ...
nai5002 天
买跌！ 这家CF制药巨头的投资逻辑依然成立
12月19日，专注于罕见病治疗的药品开发公司Vertex ...
Vertex股票被摩根大通评为增持，突显具吸引力的买入机会
周一，摩根大通对纳斯达克上市的Vertex Pharmaceuticals Incorporated（股票代码：VRTX）的目标价做出了微调，从503.00美元下调至500.00美元。该公司维持了对该股票的增持评级。根据 InvestingPro 数据，该股票目前交易价格为397.27美元，过去一周下跌了15%。此次调整是在Alyf trek获得提前批准并符合市场预期后做出的。
腾讯网3 天
摩根大通下调Vertex目标价至500美元
摩根大通：将Vertex Pharmaceuticals的目标价从503美元下调至500美元，但维持“增持”评级。(格隆汇) ...
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
Shares of Vertex Pharmaceuticals Inc. VRTX slid 0.46% to $408.76 Friday, on what proved to be an all-around rough trading ...
Vertex股票维持买入评级，2025年管线更新可能带来上涨潜力
周一，Truist Securities调整了市值1,010亿美元的知名生物技术公司Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)的目标价。该股票在过去一周下跌超过15%，承受了巨大压力。该公司分析师将目标价从之前的550美元下调至460美元，同时维持对该股票的买入评级。根据 InvestingPro ...
腾讯网13 天
2024制药并购：百亿美元难再来
正如预期的那样，今年制药公司对并购仍有兴趣，但相较于大型并购，制药公司更倾向于小额交易。迄今为止宣布的最大额的一笔交易是Novo Holdings拟以165亿美元收购CDMO公司Catalent。
Jim Cramer on Vertex Pharmaceuticals Incporated (VRTX): ‘This Is Hardly Down For The Year ...
We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In this article, we are going ...
Nasdaq2 天
Vertex Pharmaceuticals Stock Is Down 13%. Here's Why You Should Buy the Dip
Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster results from a late-stage clinical trial. But far from being a reason to ...
nai5006 天
这三只美股医疗股票或将迎来“圣诞上涨行情”
圣诞老人即将出发，将礼物送到世界各地的小朋友手中。不过，圣诞老人每年也会给投资者送上一份大礼，也就是所谓的“圣诞上涨行情”（Santa Claus Rally）。具体到医疗行业，艾伯维（AbbVie，ABBV）、诺和诺德（Novo ...